Nephros (NEPH) Gross Margin Growth (3y) (2013 - 2026)
Nephros (NEPH) Gross Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 104.00 |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 341.00 |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | 306.00 |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 382.00 |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | - |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | -92.00 |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 94.00 |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 156.00 |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | -489.00 |
| 10 | Nephros | 45.71 Mn | 41.01 Mn | 4.03 Mn | 826.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 826.00 |
| Mar 31, 2026 | 32.00 |
| Dec 31, 2025 | -61.00 |
| Sep 30, 2025 | 2,956.00 |
| Jun 30, 2025 | 1,430.00 |
| Mar 31, 2025 | 1,590.00 |
| Dec 31, 2024 | 973.00 |
| Sep 30, 2024 | 5,907.00 |
| Jun 30, 2024 | 253.00 |
| Mar 31, 2024 | 409.00 |
| Dec 31, 2023 | 632.00 |
| Sep 30, 2023 | 88.00 |
| Jun 30, 2023 | 189.00 |
| Mar 31, 2023 | -186.00 |
| Dec 31, 2022 | -112.00 |
| Sep 30, 2022 | -2,714.00 |
| Jun 30, 2022 | -1,026.00 |
| Mar 31, 2022 | -764.00 |
| Dec 31, 2021 | -496.00 |
| Sep 30, 2021 | -5,320.00 |